+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bacterial Vaginosis Drug Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Route of Administration, Dosage Form, Distribution Channel, and Geography

  • PDF Icon

    Report

  • 184 Pages
  • February 2025
  • Region: Global
  • The Insight Partners
  • ID: 6054426
Description Jump to:
According to our new research study on “Bacterial Vaginosis Drug Market Forecast to 2031 -Global Analysis - by Type, Route of Administration, Dosage Form, and Distribution Channel, and Geography,” the market is anticipated to grow from US$ 2.15 billion in 2024 and is projected to reach US$ 3.82 billion by 2031; it is expected to register a CAGR of 8.3% during 2024-2031. Rising prevalence of bacterial vaginosis, and the increased focus on developing novel and targeted therapies are contributing to the growing Bacterial Vaginosis Drug market size. However, the high recurrence rate and treatment adherence challenges hampers the Bacterial Vaginosis Drug market growth. Further, rising inclination toward microbiome therapies and probiotics are expected to bring in new Bacterial Vaginosis Drug market trends in the coming years.
In terms of revenue, North America dominated the market in 2024. It is estimated to dominate the global market during the forecast period. The US is the largest market for bacterial vaginosis drugs in the world. In the US, the bacterial vaginosis drug market is experiencing significant growth due to the increasing prevalence of BV, rising awareness about women's health, and ongoing efforts for the development of innovative treatments. BV is one of the most common vaginal infections in women, particularly affecting those of reproductive age. According to a report by Medscape in 2024, approximately one-third of adult women in the US, i.e., ~22 million females, are affected by BV annually, and 10 million women visit clinics for abnormal vaginal discharge. It is often linked to factors such as sexual activity, douching, and hormonal changes; nonetheless, there is uncertainty around the exact causes of BV. The primary therapeutic options available for treating BV include antibiotics approved by the US Food and Drug Administration (FDA), such as metronidazole and clindamycin. Metronidazole, often available in oral and topical forms, is considered the first-line treatment for BV. Clindamycin is also commonly available in both oral and topical formulations. Newer drugs and formulations, such as probiotics and phage therapy, are also emerging to help restore the natural vaginal flora, thereby reducing the recurrence of BV.
Government initiatives in the US play a key role in creating and spreading awareness about vaginosis in the population. The National Institutes of Health (NIH) funds research into the causes, treatment, and prevention of BV. The NIH's efforts have led to a deeper understanding of the microbiome and its role in causing BV, which is crucial for developing more targeted therapies. Centers for Disease Control and Prevention (CDC) provide guidelines and recommendations to improve the diagnosis and management of BV. These initiatives help standardize care and ensure that patients receive the most effective treatment. Additionally, the National Institute of Child Health and Human Development (NICHD, a federal agency) and NIH are dedicated to understanding BV and educating women about its causes and prevention. NICHD funds and conducts research on the risks associated with BV and methods for its prevention and treatment.

Bacterial Vaginosis Drug Market Analysis

Strategic Initiatives by Market Players to Provide Market Opportunities in Future

Companies operating in the bacterial vaginosis drugs market constantly focus on strategic developments such as product approvals, collaborations, funding, agreements, and new product launches, which help them improve their sales, increase their geographic reach, and reinforce their capacities to cater to a greater than existing customer base. A few strategic initiatives by key players operating in the bacterial vaginosis drugs market are mentioned below.
  • In November 2024, Freya Biosciences received US$ 10.4 million in strategic investment from the Bill & Melinda Gates Foundation, with US$ 1.4 million in additional financing from the current investor - Export and Investment Fund of Denmark (EIFO). The company plans to use these funds to develop microbial immunotherapies for the treatment of BV to address the risk of preterm birth along with other indications potentially affecting maternal and newborn health.
  • In March 2022, Organon and Daré Bioscience, Inc. entered into an agreement whereby Organon will license global rights to XACIATO (clindamycin phosphate vaginal gel, 2%). With this, XACIATO received both Qualified Infectious Disease Product (QIDP) and Fast Track designations from the US Food and Drug Administration (FDA) for the treatment of bacterial vaginosis.
  • In February 2022, Lupin Pharmaceuticals Inc. received FDA approval for a supplemental New Drug Application (sNDA) to increase the use of SOLOSEC (secnidazole) for the treatment of BV among female patients aged 12 or older; the approval also entailed the treatment of trichomoniasis among patients from the said age group.
  • In December 2021, the FDA approved XACIATO (clindamycin phosphate vaginal gel, 2%) manufactured by Daré Bioscience, Inc. for the treatment of bacterial vaginosis in females of age 12 years or more.
  • In February 2021, Rebiotix (Ferring) and MyBiotics collaborated to develop live microbiome-based therapeutics for applications in reproductive medicine and maternal health. This collaboration aims to create live microbiota-based biotherapeutics for bacterial vaginosis among women of childbearing age, which may be associated with the increased risk of miscarriage and complications in pregnancy and fertility.
Therefore, ongoing funding, product launches and approvals, and collaborations are expected to create ample opportunities for the growth of the bacterial vaginosis drugs market in the coming years.

Bacterial Vaginosis Drug Market Report Segmentation Analysis

Key segments that contributed to the derivation of the Bacterial Vaginosis Drug market analysis are type, route of administration, dosage form, and distribution channel.
  • Based on type, the bacterial vaginosis drug market is segmented into prescription drugs and over-the-counter drugs. The prescription drugs segment held a larger share of the market in 2024.
  • In terms of route of administration, the bacterial vaginosis drug market is categorized into oral, vaginal, and topical. The oral segment dominated the market in 2024.
  • In terms of dosage form, the bacterial vaginosis drug market is categorized into pills, creams, gels, solutions/washes, and others. The pills segment dominated the market in 2024.
  • In terms of distribution channel, the bacterial vaginosis drug market is categorized into hospital pharmacies, online pharmacies, and retail pharmacies. The hospital pharmacies segment dominated the market in 2024.

Bacterial Vaginosis Drug Market: Competitive Landscape and Key Developments

Bayer AG, Pfizer Inc, Sanofi SA, Starpharma Holdings Limited, Viatris Inc, Glenmark Pharmaceuticals Ltd, Lupin Ltd, Sun Pharmaceutical Industries Ltd, Organon & Co, Duchesnay Inc., Canada are among the key companies operating in the Bacterial Vaginosis Drug market.
European Journal of Obstetrics & Gynecology and Reproductive Biology, National Institutes of Health, Medscape, Government of Canada, UN World Population Prospects 2024, Eurostat, European Commission, Australian Government’s Department of Health and Aged Care, World Bank, and International Trade Administration are among the primary and secondary sources referred to while preparing the Bacterial Vaginosis Drug market report.

Reasons to Buy

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the bacterial vaginosis drug market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the bacterial vaginosis drug market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the   market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table of Contents

1. Introduction
1.1 The Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation
3.2.2 Macro-economic factor analysis
3.2.3 Developing base number
3.2.4 Data Triangulation
3.2.5 Country level data
4. Bacterial Vaginosis Drug Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Incidence Rate: Bacterial Vaginosis
5. Bacterial Vaginosis Drug Market - Key Market Dynamics
5.1 Bacterial Vaginosis Drug Market - Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Prevalence of Bacterial Vaginosis
5.2.2 Increased Focus on Developing Novel and Targeted Therapies
5.3 Market Restraints
5.3.1 High Recurrence Rate and Treatment Adherence Challenges
5.4 Market Opportunities
5.4.1 Strategic Initiatives by Market Players
5.5 Future Trends
5.5.1 Rising Inclination Toward Microbiome Therapies and Probiotics
5.6 Impact of Drivers and Restraints
6. Bacterial Vaginosis Drug Market - Global Market Analysis
6.1 Bacterial Vaginosis Drug Market Revenue (US$ Million), 2021-2031
6.2 Bacterial Vaginosis Drug Market Forecast Analysis
7. Bacterial Vaginosis Drug Market Analysis - by Type
7.1 Prescription Drugs (Rx)
7.1.1 Overview
7.1.2 Prescription Drugs (Rx): Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Over-the-counter Drugs (OTC)
7.2.1 Overview
7.2.2 Over-the-counter Drugs (OTC): Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
8. Bacterial Vaginosis Drug Market Analysis - by Route of Administration
8.1 Oral
8.1.1 Overview
8.1.2 Oral: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Vaginal
8.2.1 Overview
8.2.2 Vaginal: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Topical
8.3.1 Overview
8.3.2 Topical: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
9. Bacterial Vaginosis Drug Market Analysis - by Dosage Form
9.1 Pills
9.1.1 Overview
9.1.2 Pills: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Creams
9.2.1 Overview
9.2.2 Creams: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Gel
9.3.1 Overview
9.3.2 Gel: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Solution or Washes
9.4.1 Overview
9.4.2 Solution or Washes: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
10. Bacterial Vaginosis Drug Market Analysis - by Distribution Channel
10.1 Hospital Pharmacies
10.1.1 Overview
10.1.2 Hospital Pharmacies: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
10.2 Online Pharmacies
10.2.1 Overview
10.2.2 Online Pharmacies: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Retail Pharmacies
10.3.1 Overview
10.3.2 Retail Pharmacies: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
11. Bacterial Vaginosis Drug Market - Geographical Analysis
11.1 North America
11.1.1 North America Bacterial Vaginosis Drug Market Overview
11.1.2 North America: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
11.1.2.1 North America: Bacterial Vaginosis Drug Market - Revenue and Forecast Analysis - by Type
11.1.2.2 North America: Bacterial Vaginosis Drug Market - Revenue and Forecast Analysis - by Route of Administration
11.1.2.3 North America: Bacterial Vaginosis Drug Market - Revenue and Forecast Analysis - by Dosage Form
11.1.2.4 North America: Bacterial Vaginosis Drug Market - Revenue and Forecast Analysis - by Distribution Channel
11.1.3 North America: Bacterial Vaginosis Drug Market - Revenue and Forecast Analysis - by Country
11.1.3.1 North America: Bacterial Vaginosis Drug Market - Revenue and Forecast Analysis - by Country
11.1.3.2 United States: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
11.1.3.2.1 United States: Bacterial Vaginosis Drug Market Breakdown, by Type
11.1.3.2.2 United States: Bacterial Vaginosis Drug Market Breakdown, by Route of Administration
11.1.3.2.3 United States: Bacterial Vaginosis Drug Market Breakdown, by Dosage Form
11.1.3.2.4 United States: Bacterial Vaginosis Drug Market Breakdown, by Distribution Channel
11.1.3.3 Canada: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
11.1.3.3.1 Canada: Bacterial Vaginosis Drug Market Breakdown, by Type
11.1.3.3.2 Canada: Bacterial Vaginosis Drug Market Breakdown, by Route of Administration
11.1.3.3.3 Canada: Bacterial Vaginosis Drug Market Breakdown, by Dosage Form
11.1.3.3.4 Canada: Bacterial Vaginosis Drug Market Breakdown, by Distribution Channel
11.1.3.4 Mexico: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
11.1.3.4.1 Mexico: Bacterial Vaginosis Drug Market Breakdown, by Type
11.1.3.4.2 Mexico: Bacterial Vaginosis Drug Market Breakdown, by Route of Administration
11.1.3.4.3 Mexico: Bacterial Vaginosis Drug Market Breakdown, by Dosage Form
11.1.3.4.4 Mexico: Bacterial Vaginosis Drug Market Breakdown, by Distribution Channel
11.2 Europe
11.2.1 Europe Bacterial Vaginosis Drug Market Overview
11.2.2 Europe: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
11.2.2.1 Europe: Bacterial Vaginosis Drug Market - Revenue and Forecast Analysis - by Type
11.2.2.2 Europe: Bacterial Vaginosis Drug Market - Revenue and Forecast Analysis - by Route of Administration
11.2.2.3 Europe: Bacterial Vaginosis Drug Market - Revenue and Forecast Analysis - by Dosage Form
11.2.2.4 Europe: Bacterial Vaginosis Drug Market - Revenue and Forecast Analysis - by Distribution Channel
11.2.3 Europe: Bacterial Vaginosis Drug Market - Revenue and Forecast Analysis - by Country
11.2.3.1 Europe: Bacterial Vaginosis Drug Market - Revenue and Forecast Analysis - by Country
11.2.3.2 Germany: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
11.2.3.2.1 Germany: Bacterial Vaginosis Drug Market Breakdown, by Type
11.2.3.2.2 Germany: Bacterial Vaginosis Drug Market Breakdown, by Route of Administration
11.2.3.2.3 Germany: Bacterial Vaginosis Drug Market Breakdown, by Dosage Form
11.2.3.2.4 Germany: Bacterial Vaginosis Drug Market Breakdown, by Distribution Channel
11.2.3.3 United Kingdom: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
11.2.3.3.1 United Kingdom: Bacterial Vaginosis Drug Market Breakdown, by Type
11.2.3.3.2 United Kingdom: Bacterial Vaginosis Drug Market Breakdown, by Route of Administration
11.2.3.3.3 United Kingdom: Bacterial Vaginosis Drug Market Breakdown, by Dosage Form
11.2.3.3.4 United Kingdom: Bacterial Vaginosis Drug Market Breakdown, by Distribution Channel
11.2.3.4 France: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
11.2.3.4.1 France: Bacterial Vaginosis Drug Market Breakdown, by Type
11.2.3.4.2 France: Bacterial Vaginosis Drug Market Breakdown, by Route of Administration
11.2.3.4.3 France: Bacterial Vaginosis Drug Market Breakdown, by Dosage Form
11.2.3.4.4 France: Bacterial Vaginosis Drug Market Breakdown, by Distribution Channel
11.2.3.5 Spain: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
11.2.3.5.1 Spain: Bacterial Vaginosis Drug Market Breakdown, by Type
11.2.3.5.2 Spain: Bacterial Vaginosis Drug Market Breakdown, by Route of Administration
11.2.3.5.3 Spain: Bacterial Vaginosis Drug Market Breakdown, by Dosage Form
11.2.3.5.4 Spain: Bacterial Vaginosis Drug Market Breakdown, by Distribution Channel
11.2.3.6 Italy: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
11.2.3.6.1 Italy: Bacterial Vaginosis Drug Market Breakdown, by Type
11.2.3.6.2 Italy: Bacterial Vaginosis Drug Market Breakdown, by Route of Administration
11.2.3.6.3 Italy: Bacterial Vaginosis Drug Market Breakdown, by Dosage Form
11.2.3.6.4 Italy: Bacterial Vaginosis Drug Market Breakdown, by Distribution Channel
11.2.3.7 Rest of Europe: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
11.2.3.7.1 Rest of Europe: Bacterial Vaginosis Drug Market Breakdown, by Type
11.2.3.7.2 Rest of Europe: Bacterial Vaginosis Drug Market Breakdown, by Route of Administration
11.2.3.7.3 Rest of Europe: Bacterial Vaginosis Drug Market Breakdown, by Dosage Form
11.2.3.7.4 Rest of Europe: Bacterial Vaginosis Drug Market Breakdown, by Distribution Channel
11.3 Asia Pacific
11.3.1 Asia Pacific Bacterial Vaginosis Drug Market Overview
11.3.2 Asia Pacific: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
11.3.2.1 Asia Pacific: Bacterial Vaginosis Drug Market - Revenue and Forecast Analysis - by Type
11.3.2.2 Asia Pacific: Bacterial Vaginosis Drug Market - Revenue and Forecast Analysis - by Route of Administration
11.3.2.3 Asia Pacific: Bacterial Vaginosis Drug Market - Revenue and Forecast Analysis - by Dosage Form
11.3.2.4 Asia Pacific: Bacterial Vaginosis Drug Market - Revenue and Forecast Analysis - by Distribution Channel
11.3.3 Asia Pacific: Bacterial Vaginosis Drug Market - Revenue and Forecast Analysis - by Country
11.3.3.1 Asia Pacific: Bacterial Vaginosis Drug Market - Revenue and Forecast Analysis - by Country
11.3.3.2 China: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
11.3.3.2.1 China: Bacterial Vaginosis Drug Market Breakdown, by Type
11.3.3.2.2 China: Bacterial Vaginosis Drug Market Breakdown, by Route of Administration
11.3.3.2.3 China: Bacterial Vaginosis Drug Market Breakdown, by Dosage Form
11.3.3.2.4 China: Bacterial Vaginosis Drug Market Breakdown, by Distribution Channel
11.3.3.3 Japan: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
11.3.3.3.1 Japan: Bacterial Vaginosis Drug Market Breakdown, by Type
11.3.3.3.2 Japan: Bacterial Vaginosis Drug Market Breakdown, by Route of Administration
11.3.3.3.3 Japan: Bacterial Vaginosis Drug Market Breakdown, by Dosage Form
11.3.3.3.4 Japan: Bacterial Vaginosis Drug Market Breakdown, by Distribution Channel
11.3.3.4 India: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
11.3.3.4.1 India: Bacterial Vaginosis Drug Market Breakdown, by Type
11.3.3.4.2 India: Bacterial Vaginosis Drug Market Breakdown, by Route of Administration
11.3.3.4.3 India: Bacterial Vaginosis Drug Market Breakdown, by Dosage Form
11.3.3.4.4 India: Bacterial Vaginosis Drug Market Breakdown, by Distribution Channel
11.3.3.5 Australia: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
11.3.3.5.1 Australia: Bacterial Vaginosis Drug Market Breakdown, by Type
11.3.3.5.2 Australia: Bacterial Vaginosis Drug Market Breakdown, by Route of Administration
11.3.3.5.3 Australia: Bacterial Vaginosis Drug Market Breakdown, by Dosage Form
11.3.3.5.4 Australia: Bacterial Vaginosis Drug Market Breakdown, by Distribution Channel
11.3.3.6 South Korea: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
11.3.3.6.1 South Korea: Bacterial Vaginosis Drug Market Breakdown, by Type
11.3.3.6.2 South Korea: Bacterial Vaginosis Drug Market Breakdown, by Route of Administration
11.3.3.6.3 South Korea: Bacterial Vaginosis Drug Market Breakdown, by Dosage Form
11.3.3.6.4 South Korea: Bacterial Vaginosis Drug Market Breakdown, by Distribution Channel
11.3.3.7 Rest of APAC: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
11.3.3.7.1 Rest of APAC: Bacterial Vaginosis Drug Market Breakdown, by Type
11.3.3.7.2 Rest of APAC: Bacterial Vaginosis Drug Market Breakdown, by Route of Administration
11.3.3.7.3 Rest of APAC: Bacterial Vaginosis Drug Market Breakdown, by Dosage Form
11.3.3.7.4 Rest of APAC: Bacterial Vaginosis Drug Market Breakdown, by Distribution Channel
11.4 Middle East and Africa
11.4.1 Middle East and Africa Bacterial Vaginosis Drug Market Overview
11.4.2 Middle East and Africa: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
11.4.2.1 Middle East and Africa: Bacterial Vaginosis Drug Market - Revenue and Forecast Analysis - by Type
11.4.2.2 Middle East and Africa: Bacterial Vaginosis Drug Market - Revenue and Forecast Analysis - by Route of Administration
11.4.2.3 Middle East and Africa: Bacterial Vaginosis Drug Market - Revenue and Forecast Analysis - by Dosage Form
11.4.2.4 Middle East and Africa: Bacterial Vaginosis Drug Market - Revenue and Forecast Analysis - by Distribution Channel
11.4.3 Middle East and Africa: Bacterial Vaginosis Drug Market - Revenue and Forecast Analysis - by Country
11.4.3.1 Middle East and Africa: Bacterial Vaginosis Drug Market - Revenue and Forecast Analysis - by Country
11.4.3.2 Saudi Arabia: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
11.4.3.2.1 Saudi Arabia: Bacterial Vaginosis Drug Market Breakdown, by Type
11.4.3.2.2 Saudi Arabia: Bacterial Vaginosis Drug Market Breakdown, by Route of Administration
11.4.3.2.3 Saudi Arabia: Bacterial Vaginosis Drug Market Breakdown, by Dosage Form
11.4.3.2.4 Saudi Arabia: Bacterial Vaginosis Drug Market Breakdown, by Distribution Channel
11.4.3.3 South Africa: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
11.4.3.3.1 South Africa: Bacterial Vaginosis Drug Market Breakdown, by Type
11.4.3.3.2 South Africa: Bacterial Vaginosis Drug Market Breakdown, by Route of Administration
11.4.3.3.3 South Africa: Bacterial Vaginosis Drug Market Breakdown, by Dosage Form
11.4.3.3.4 South Africa: Bacterial Vaginosis Drug Market Breakdown, by Distribution Channel
11.4.3.4 United Arab Emirates: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
11.4.3.4.1 United Arab Emirates: Bacterial Vaginosis Drug Market Breakdown, by Type
11.4.3.4.2 United Arab Emirates: Bacterial Vaginosis Drug Market Breakdown, by Route of Administration
11.4.3.4.3 United Arab Emirates: Bacterial Vaginosis Drug Market Breakdown, by Dosage Form
11.4.3.4.4 United Arab Emirates: Bacterial Vaginosis Drug Market Breakdown, by Distribution Channel
11.4.3.5 Rest of Middle East and Africa: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
11.4.3.5.1 Rest of Middle East and Africa: Bacterial Vaginosis Drug Market Breakdown, by Type
11.4.3.5.2 Rest of Middle East and Africa: Bacterial Vaginosis Drug Market Breakdown, by Route of Administration
11.4.3.5.3 Rest of Middle East and Africa: Bacterial Vaginosis Drug Market Breakdown, by Dosage Form
11.4.3.5.4 Rest of Middle East and Africa: Bacterial Vaginosis Drug Market Breakdown, by Distribution Channel
11.5 South and Central America
11.5.1 South and Central America Bacterial Vaginosis Drug Market Overview
11.5.2 South and Central America: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
11.5.2.1 South and Central America: Bacterial Vaginosis Drug Market - Revenue and Forecast Analysis - by Type
11.5.2.2 South and Central America: Bacterial Vaginosis Drug Market - Revenue and Forecast Analysis - by Route of Administration
11.5.2.3 South and Central America: Bacterial Vaginosis Drug Market - Revenue and Forecast Analysis - by Dosage Form
11.5.2.4 South and Central America: Bacterial Vaginosis Drug Market - Revenue and Forecast Analysis - by Distribution Channel
11.5.3 South and Central America: Bacterial Vaginosis Drug Market - Revenue and Forecast Analysis - by Country
11.5.3.1 South and Central America: Bacterial Vaginosis Drug Market - Revenue and Forecast Analysis - by Country
11.5.3.2 Brazil: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
11.5.3.2.1 Brazil: Bacterial Vaginosis Drug Market Breakdown, by Type
11.5.3.2.2 Brazil: Bacterial Vaginosis Drug Market Breakdown, by Route of Administration
11.5.3.2.3 Brazil: Bacterial Vaginosis Drug Market Breakdown, by Dosage Form
11.5.3.2.4 Brazil: Bacterial Vaginosis Drug Market Breakdown, by Distribution Channel
11.5.3.3 Argentina: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
11.5.3.3.1 Argentina: Bacterial Vaginosis Drug Market Breakdown, by Type
11.5.3.3.2 Argentina: Bacterial Vaginosis Drug Market Breakdown, by Route of Administration
11.5.3.3.3 Argentina: Bacterial Vaginosis Drug Market Breakdown, by Dosage Form
11.5.3.3.4 Argentina: Bacterial Vaginosis Drug Market Breakdown, by Distribution Channel
11.5.3.4 Rest of South and Central America: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
11.5.3.4.1 Rest of South and Central America: Bacterial Vaginosis Drug Market Breakdown, by Type
11.5.3.4.2 Rest of South and Central America: Bacterial Vaginosis Drug Market Breakdown, by Route of Administration
11.5.3.4.3 Rest of South and Central America: Bacterial Vaginosis Drug Market Breakdown, by Dosage Form
11.5.3.4.4 Rest of South and Central America: Bacterial Vaginosis Drug Market Breakdown, by Distribution Channel
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Bacterial Vaginosis Drug Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Bayer AG
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Pfizer Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Sanofi SA
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Starpharma Holdings Limited
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Viatris Inc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Glenmark Pharmaceuticals Ltd
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Lupin Ltd
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Sun Pharmaceutical Industries Ltd
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Organon & Co
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Duchesnay Inc., Canada
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Publisher
14.2 Glossary of Terms for Bacterial Vaginosis Drug Market
List Of Tables
Table 1. Bacterial Vaginosis Drug Market Segmentation
Table 2. Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million) - by Type
Table 3. Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million) - by Route of Administration
Table 4. Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
Table 5. Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel
Table 6. North America: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 7. North America: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Route of Administration
Table 8. North America: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Dosage Form
Table 9. North America: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 10. North America: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Country
Table 11. United States: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 12. United States: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Route of Administration
Table 13. United States: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Dosage Form
Table 14. United States: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 15. Canada: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 16. Canada: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Route of Administration
Table 17. Canada: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Dosage Form
Table 18. Canada: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 19. Mexico: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 20. Mexico: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Route of Administration
Table 21. Mexico: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Dosage Form
Table 22. Mexico: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 23. Europe: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 24. Europe: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Route of Administration
Table 25. Europe: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Dosage Form
Table 26. Europe: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 27. Europe: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Country
Table 28. Germany: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 29. Germany: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Route of Administration
Table 30. Germany: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Dosage Form
Table 31. Germany: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 32. United Kingdom: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 33. United Kingdom: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Route of Administration
Table 34. United Kingdom: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Dosage Form
Table 35. United Kingdom: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 36. France: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 37. France: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Route of Administration
Table 38. France: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Dosage Form
Table 39. France: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 40. Spain: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 41. Spain: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Route of Administration
Table 42. Spain: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Dosage Form
Table 43. Spain: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 44. Italy: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 45. Italy: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Route of Administration
Table 46. Italy: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Dosage Form
Table 47. Italy: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 48. Rest of Europe: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 49. Rest of Europe: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Route of Administration
Table 50. Rest of Europe: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Dosage Form
Table 51. Rest of Europe: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 52. Asia Pacific: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 53. Asia Pacific: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Route of Administration
Table 54. Asia Pacific: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Dosage Form
Table 55. Asia Pacific: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 56. Asia Pacific: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Country
Table 57. China: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 58. China: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Route of Administration
Table 59. China: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Dosage Form
Table 60. China: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 61. Japan: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 62. Japan: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Route of Administration
Table 63. Japan: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Dosage Form
Table 64. Japan: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 65. India: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 66. India: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Route of Administration
Table 67. India: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Dosage Form
Table 68. India: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 69. Australia: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 70. Australia: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Route of Administration
Table 71. Australia: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Dosage Form
Table 72. Australia: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 73. South Korea: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 74. South Korea: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Route of Administration
Table 75. South Korea: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Dosage Form
Table 76. South Korea: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 77. Rest of APAC: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 78. Rest of APAC: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Route of Administration
Table 79. Rest of APAC: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Dosage Form
Table 80. Rest of APAC: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 81. Middle East and Africa: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 82. Middle East and Africa: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Route of Administration
Table 83. Middle East and Africa: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Dosage Form
Table 84. Middle East and Africa: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 85. Middle East and Africa: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Country
Table 86. Saudi Arabia: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 87. Saudi Arabia: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Route of Administration
Table 88. Saudi Arabia: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Dosage Form
Table 89. Saudi Arabia: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 90. South Africa: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 91. South Africa: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Route of Administration
Table 92. South Africa: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Dosage Form
Table 93. South Africa: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 94. United Arab Emirates: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 95. United Arab Emirates: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Route of Administration
Table 96. United Arab Emirates: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Dosage Form
Table 97. United Arab Emirates: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 98. Rest of Middle East and Africa: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 99. Rest of Middle East and Africa: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Route of Administration
Table 100. Rest of Middle East and Africa: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Dosage Form
Table 101. Rest of Middle East and Africa: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 102. South and Central America: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 103. South and Central America: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Route of Administration
Table 104. South and Central America: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Dosage Form
Table 105. South and Central America: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 106. South and Central America: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Country
Table 107. Brazil: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 108. Brazil: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Route of Administration
Table 109. Brazil: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Dosage Form
Table 110. Brazil: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 111. Argentina: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 112. Argentina: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Route of Administration
Table 113. Argentina: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Dosage Form
Table 114. Argentina: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 115. Rest of South and Central America: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 116. Rest of South and Central America: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Route of Administration
Table 117. Rest of South and Central America: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Dosage Form
Table 118. Rest of South and Central America: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 119. Recent Organic Growth Strategies in the Bacterial Vaginosis Drug Market
Table 120. Recent Inorganic Growth Strategies in the Bacterial Vaginosis Drug Market
Table 121. Glossary of Terms
List Of Figures
Figure 1. Bacterial Vaginosis Drug Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Bacterial Vaginosis Drug Market Revenue (US$ Million), 2021-2031
Figure 5. Bacterial Vaginosis Drug Market Share (%) - by Type (2024 and 2031)
Figure 6. Prescription Drugs (Rx): Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Over-the-counter Drugs (OTC): Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Bacterial Vaginosis Drug Market Share (%) - by Route of Administration (2024 and 2031)
Figure 9. Oral: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Vaginal: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Topical: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Bacterial Vaginosis Drug Market Share (%) - by Dosage Form (2024 and 2031)
Figure 13. Pills: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Creams: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Gel: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Solution or Washes: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Others: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Bacterial Vaginosis Drug Market Share (%) - by Distribution Channel (2024 and 2031)
Figure 19. Hospital Pharmacies: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Online Pharmacies: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
Figure 21. Retail Pharmacies: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031 (US$ Million)
Figure 22. North America: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million)
Figure 23. North America: Bacterial Vaginosis Drug Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 24. United States: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million)
Figure 25. Canada: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million)
Figure 26. Mexico: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million)
Figure 27. Europe: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million)
Figure 28. Europe: Bacterial Vaginosis Drug Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 29. Germany: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million)
Figure 30. United Kingdom: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million)
Figure 31. France: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million)
Figure 32. Spain: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million)
Figure 33. Italy: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million)
Figure 34. Rest of Europe: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million)
Figure 35. Asia Pacific: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million)
Figure 36. Asia Pacific: Bacterial Vaginosis Drug Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 37. China: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million)
Figure 38. Japan: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million)
Figure 39. India: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million)
Figure 40. Australia: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million)
Figure 41. South Korea: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million)
Figure 42. Rest of APAC: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million)
Figure 43. Middle East and Africa: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million)
Figure 44. Middle East and Africa: Bacterial Vaginosis Drug Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 45. Saudi Arabia: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million)
Figure 46. South Africa: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million)
Figure 47. United Arab Emirates: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million)
Figure 48. Rest of Middle East and Africa: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million)
Figure 49. South and Central America: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million)
Figure 50. South and Central America: Bacterial Vaginosis Drug Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 51. Brazil: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million)
Figure 52. Argentina: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million)
Figure 53. Rest of South and Central America: Bacterial Vaginosis Drug Market - Revenue and Forecast to 2031(US$ Million)
Figure 54. Growth Strategies in the Bacterial Vaginosis Drug Market

Companies Mentioned

  • Bayer AG
  • Pfizer Inc
  • Sanofi SA
  • Starpharma Holdings Limited
  • Viatris Inc.
  • Glenmark Pharmaceuticals Ltd
  • Lupin Ltd
  • Sun Pharmaceutical Industries Ltd
  • Organon & Co
  • Duchesnay Inc., Canada

Table Information

Report AttributeDetails
No. of Pages184
PublishedFebruary 2025
Forecast Period2024 - 2031
Estimated Market Value ( USD ) in 2024 $ 2.15 Billion
Forecasted Market Value ( USD ) by 2031 $ 3.82 Billion
Compound Annual Growth Rate8.3%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Bacterial Vaginosis Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030 - Product Image

Bacterial Vaginosis Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • Report
  • 120 Pages
  • Global
From
Bacterial Vaginosis Drugs Market by Drug Type, Drug Form, Distribution Channel, Patient Demographics, End User - Global Forecast 2025-2030 - Product Image

Bacterial Vaginosis Drugs Market by Drug Type, Drug Form, Distribution Channel, Patient Demographics, End User - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Bacterial vaginosis - Pipeline Insight, 2024 - Product Image

Bacterial vaginosis - Pipeline Insight, 2024

  • Clinical Trials
  • 40 Pages
  • Global
From
Bacterial Vaginosis Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type - Product Image

Bacterial Vaginosis Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type

  • Report
  • 91 Pages
  • Global
From
2024 Global Forecast for Bacterial Vaginosis Therapeutics Market (2025-2030 Outlook)-High Tech & Emerging Markets Report - Product Image

2024 Global Forecast for Bacterial Vaginosis Therapeutics Market (2025-2030 Outlook)-High Tech & Emerging Markets Report

  • Report
  • 132 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.